New Advances in Cancer Cell Biology: Biomarkers and Therapeutic Targets
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".
Deadline for manuscript submissions: 30 October 2025 | Viewed by 49
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer remains a leading cause of mortality worldwide. As a leading cause of global mortality, cancer compels the relentless carrying out of research. Understanding its intricate nature, shaped by genetic mutations, epigenetic changes, and complex tumor microenvironments, requires a multifaceted approach, extending beyond cellular studies to comprehensive in vivo investigations.
The purpose of this Special Issue is to assemble cutting-edge research exploring the latest developments in this dynamic field, ranging from the identification and validation of novel biomarkers, crucial for early detection and prognosis, to the development of personalized treatment strategies, with a special focus on emerging therapeutic targets. This Special Issue focuses on innovative approaches that promise to revolutionize cancer therapy, covering areas from the molecular intricacies of tumor microenvironments to the clinical applications of precision medicine.
This Special Issue aims to provide a comprehensive overview of the current progress in cancer cell biology, ultimately facilitating the development of improved clinical outcomes for patients.
Dr. Verena Damiani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- biomarkers
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
